Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125311831> ?p ?o ?g. }
- W2125311831 endingPage "2754" @default.
- W2125311831 startingPage "2744" @default.
- W2125311831 abstract "A novel recombinant human growth hormone (rhGH) fusion protein (VRS-317) was designed to minimize receptor-mediated clearance through a reduction in receptor binding without mutations to rhGH by genetically fusing with XTEN amino acid sequences to the N-terminus and the C-terminus of the native hGH sequence. Although in vitro potency of VRS-317 was reduced approximately 12-fold compared with rhGH, in vivo potency was increased because of the greatly prolonged exposure to the target tissues and organs. VRS-317 was threefold more potent than daily rhGH in hypophysectomized rats and fivefold more potent than daily rhGH in juvenile monkeys. In juvenile monkeys, a monthly dose of 1.4 mg/kg VRS-317 (equivalent to 0.26 mg/kg rhGH) caused a sustained pharmacodynamic response for 1 month equivalent to 0.05 mg/kg/day rhGH (1.4 mg/kg rhGH total over 28 days). In monkeys, VRS-317, having a terminal elimination half-life of approximately 110 h, was rapidly and near-completely absorbed, and was well tolerated with no observed adverse effects after every alternate week subcutaneous dosing for 14 weeks. VRS-317 also did not cause lipoatrophy in pig and monkey studies. VRS-317 is currently being studied in GH-deficient patients to confirm the observations in these animal studies." @default.
- W2125311831 created "2016-06-24" @default.
- W2125311831 creator A5018783910 @default.
- W2125311831 creator A5020651894 @default.
- W2125311831 creator A5026964719 @default.
- W2125311831 creator A5028351026 @default.
- W2125311831 creator A5039597999 @default.
- W2125311831 creator A5042446707 @default.
- W2125311831 creator A5061394106 @default.
- W2125311831 creator A5061800868 @default.
- W2125311831 creator A5074940267 @default.
- W2125311831 date "2012-08-01" @default.
- W2125311831 modified "2023-10-05" @default.
- W2125311831 title "A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life" @default.
- W2125311831 cites W1989641932 @default.
- W2125311831 cites W2003604055 @default.
- W2125311831 cites W2014983285 @default.
- W2125311831 cites W2032563880 @default.
- W2125311831 cites W2042399930 @default.
- W2125311831 cites W2052085008 @default.
- W2125311831 cites W2059144169 @default.
- W2125311831 cites W2073034978 @default.
- W2125311831 cites W2073047768 @default.
- W2125311831 cites W2088649681 @default.
- W2125311831 cites W2106141790 @default.
- W2125311831 cites W2132043181 @default.
- W2125311831 cites W2140304772 @default.
- W2125311831 cites W2337232373 @default.
- W2125311831 cites W4256578584 @default.
- W2125311831 doi "https://doi.org/10.1002/jps.23229" @default.
- W2125311831 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3427893" @default.
- W2125311831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22678811" @default.
- W2125311831 hasPublicationYear "2012" @default.
- W2125311831 type Work @default.
- W2125311831 sameAs 2125311831 @default.
- W2125311831 citedByCount "65" @default.
- W2125311831 countsByYear W21253118312012 @default.
- W2125311831 countsByYear W21253118312013 @default.
- W2125311831 countsByYear W21253118312014 @default.
- W2125311831 countsByYear W21253118312015 @default.
- W2125311831 countsByYear W21253118312016 @default.
- W2125311831 countsByYear W21253118312017 @default.
- W2125311831 countsByYear W21253118312018 @default.
- W2125311831 countsByYear W21253118312019 @default.
- W2125311831 countsByYear W21253118312020 @default.
- W2125311831 countsByYear W21253118312021 @default.
- W2125311831 countsByYear W21253118312022 @default.
- W2125311831 countsByYear W21253118312023 @default.
- W2125311831 crossrefType "journal-article" @default.
- W2125311831 hasAuthorship W2125311831A5018783910 @default.
- W2125311831 hasAuthorship W2125311831A5020651894 @default.
- W2125311831 hasAuthorship W2125311831A5026964719 @default.
- W2125311831 hasAuthorship W2125311831A5028351026 @default.
- W2125311831 hasAuthorship W2125311831A5039597999 @default.
- W2125311831 hasAuthorship W2125311831A5042446707 @default.
- W2125311831 hasAuthorship W2125311831A5061394106 @default.
- W2125311831 hasAuthorship W2125311831A5061800868 @default.
- W2125311831 hasAuthorship W2125311831A5074940267 @default.
- W2125311831 hasBestOaLocation W21253118311 @default.
- W2125311831 hasConcept C111113717 @default.
- W2125311831 hasConcept C112705442 @default.
- W2125311831 hasConcept C113675107 @default.
- W2125311831 hasConcept C126322002 @default.
- W2125311831 hasConcept C134018914 @default.
- W2125311831 hasConcept C142462285 @default.
- W2125311831 hasConcept C150903083 @default.
- W2125311831 hasConcept C170493617 @default.
- W2125311831 hasConcept C185592680 @default.
- W2125311831 hasConcept C197934379 @default.
- W2125311831 hasConcept C202751555 @default.
- W2125311831 hasConcept C203014093 @default.
- W2125311831 hasConcept C207001950 @default.
- W2125311831 hasConcept C2777288759 @default.
- W2125311831 hasConcept C2778328710 @default.
- W2125311831 hasConcept C2779546735 @default.
- W2125311831 hasConcept C2984496839 @default.
- W2125311831 hasConcept C2993143319 @default.
- W2125311831 hasConcept C3013748606 @default.
- W2125311831 hasConcept C55493867 @default.
- W2125311831 hasConcept C57992300 @default.
- W2125311831 hasConcept C71315377 @default.
- W2125311831 hasConcept C71924100 @default.
- W2125311831 hasConcept C86803240 @default.
- W2125311831 hasConcept C98274493 @default.
- W2125311831 hasConceptScore W2125311831C111113717 @default.
- W2125311831 hasConceptScore W2125311831C112705442 @default.
- W2125311831 hasConceptScore W2125311831C113675107 @default.
- W2125311831 hasConceptScore W2125311831C126322002 @default.
- W2125311831 hasConceptScore W2125311831C134018914 @default.
- W2125311831 hasConceptScore W2125311831C142462285 @default.
- W2125311831 hasConceptScore W2125311831C150903083 @default.
- W2125311831 hasConceptScore W2125311831C170493617 @default.
- W2125311831 hasConceptScore W2125311831C185592680 @default.
- W2125311831 hasConceptScore W2125311831C197934379 @default.
- W2125311831 hasConceptScore W2125311831C202751555 @default.
- W2125311831 hasConceptScore W2125311831C203014093 @default.
- W2125311831 hasConceptScore W2125311831C207001950 @default.
- W2125311831 hasConceptScore W2125311831C2777288759 @default.